Understanding Brain Changes in Alzheimer's Disease

Spatial Transcriptomics for Investigating the Interaction between TDP-43 Proteinopathy and Hippocampal Sclerosis in Alzheimer's Disease

NIH-funded research Utah State Higher Education System--University of Utah · NIH-11181646

This project aims to understand how specific protein changes and brain scarring interact in Alzheimer's disease by looking closely at gene activity in affected brain areas.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUtah State Higher Education System--University of Utah NIH-funded
Lab location1 site (Salt Lake City, United States)
Project IDNIH-11181646 on NIH RePORTER

What this research studies

Alzheimer's disease affects millions, and while we know a lot, we still have questions about how certain brain changes contribute to the disease. This work focuses on two key features: hippocampal sclerosis, which is scarring in a memory-related part of the brain, and TDP-43 proteinopathy, which involves abnormal proteins. We want to see how these two problems work together to affect gene activity in the brain. By using advanced techniques to map gene expression in specific brain regions, we hope to uncover new details about how these changes contribute to Alzheimer's.

Who could benefit from this research

Good fit: This foundational research is relevant for anyone affected by Alzheimer's disease, as it seeks to clarify underlying disease mechanisms.

Not a fit: Patients will not directly participate in this laboratory-based research, so there is no immediate personal benefit.

Why it matters

Potential benefit: If successful, this work could lead to a deeper understanding of Alzheimer's disease, potentially identifying new targets for future treatments.

How similar studies have performed: While much is known about Alzheimer's, the specific interplay between TDP-43 proteinopathy and hippocampal sclerosis at the gene level remains largely unexplored, making this a novel approach.

Where this research is happening

Salt Lake City, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's DiseaseAlzheimer's disease brain
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.